17 Aug 2026Open access
Enhanced school-based vision screening in Kumasi, Ghana: a pilot study to assess feasibilityPublisher siteFrontiers in Medicine, Ophthalmology and Visual Impairment Studies
Active, last published 2026
In ophthalmology and visual impairment studies
Elisha Eric
Arkhurst
Scholar“Research focused on Ophthalmology and Visual Impairment Studies and adjacent fields.”
Kwame Nkrumah University
Zambia
Claim Your ProfileZambia1
H-index
24
Citations
Elisha has not officially claimed their profile. If you are Elisha, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
lisha Eric Arkhurst is a researcher working on Ophthalmology and Visual Impairment Studies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Elisha's work has been cited 24 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Ophthalmology and Visual Impairment Studies×3Ophthalmology and Visual Health Research×2
04 · Where I am
Affiliations
Affiliation on published researchKwame Nkrumah University of Science and Technology, ZambiaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works4 Feb 2026Open access
Individual and School-Level Factors Associated with Pediatric Eye Disorders and Referral Adherence in an Enhanced School-Based Vision Screening Program in GhanaPublisher siteExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Elisha?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you